Canada Markets closed

Adaptive Biotechnologies Corporation (ADPT)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
33.89+1.91 (+5.97%)
At close: 4:00PM EDT
34.00 +0.11 (+0.32%)
After hours: 04:25PM EDT
Sign in to post a message.
  • C
    Chiefmadhatter117
    Down 6% and not 1 post?
  • a
    anesth2go
    A lot more COVID home test kits will be needed soon.
  • k
    kastenz
    Received this Sat Oct-02 from the company: highlights of PDF cover Lyme and COVID reported this weekend.

    If I was a patient or doctor I'd want to know that a natural infection can be distinguished from a vaccine response

    Real-world data show T-Detect™ COVID can detect prior SARS-CoV-2 infection nearly 12 months after initial diagnosis in some patients

    New research demonstrates T-cell testing using T-cell receptor (TCR) repertoire characterization can distinguish natural SARS-CoV-2 infection from COVID-19 vaccine response

    Late-breaking data show TCR repertoire characterization is nearly two times more sensitive than the standard two-tiered testing (STTT) at identifying Lyme disease
  • Y
    Yahoo Finance Insights
    Adaptive Biotechnologies is up 6.07% to 33.92
  • k
    kastenz
    Two presentations Sep-29 on COVID epitopes regarding vaccine development and disease testing. ("IDWeek)
  • k
    kastenz
    Two friends are being retested for COVID. I get the impression front line medical staffing is not aware it's possible to distinguish between natural infection and vaccinaton.

    https://investors.adaptivebiotech.com/news-releases/news-release-details/adaptive-biotechnologies-presents-new-data-during-idweek
  • k
    kastenz
    Morgan Stanley PT $75 as of mid August. Plenty of upside from 36, with Lyme Disease and immune milestones in months.
  • k
    kastenz
    Technical, daily spinning tops (indicate trend change);
    1. Had several mid-August, then up 30% in two weeks.
    2. Have the third in one week today, if close is about 32.5 today.
    Events ahead, ER Nov-03. Runup into Nov-03 would not surprise.
  • k
    kastenz
    Important to remember ClonoSeq MRD is used in most blood cancer trials as The Primary Outcome Measure
  • R
    RV
    Nice- anybody wants to check it out:

    The thread is very heartening if you have a position in ADPT:

    Simon Barnett@sbarnettARK

    Once Adaptive Biotech launches T-Detect Lyme, and inexorably more autoimmune indications, it may be the only molecular diagnostic company that can add new ‘products’ solely through over-the-air (OTA) software updates.7:35 PM · Aug 19, 2021·Twitter for iPhone
  • T
    Tigat
    ADPT is the best losing stock in my portfolio (thank you Jeff brown and Whitney Tilson).
    All of the ADPT losses in 2021 will mitigate my gains this year.
  • R
    RV
    ARK buy:

    ADPT
    September 7, 2021 BUY 192885 0.09% ARKG
  • T
    Tigat
    New to board, but invested on recommendation of a guy named Jeff Brown vouched for by a Whitney tilson. Advice was to buy as long as price was below $50. This effing stock has been in the 30’s for the 3 weeks since I bought.
    I won’t lose money but cashing out next week. If you get advice from brown or tilson, BUYER BEWARE.
  • R
    RV
    Simon Barnett@sbarnettARK

    Replying to @wolfejosh

    Yes, also ending the diagnostic odyssey for Lyme, and potentially dozens of autoimmune diseases with a simple, one-and-done blood test. https://investors.adaptivebiotech.com/news-releases/news-release-details/adaptive-biotechnologies-launches-national-clinical-trial

    Current tests are highly inaccurate, resulting in lengthy diagnostic journey

    An oral medication being developed by a California biopharmaceutical company is in phase-one trials in people. A French biotech company, Valneva, is currently running phase-two clinical trials in the U.S. and Europe for a Lyme disease vaccine. Valneva signed a deal with Pfizer last year to commercialize what it’s calling VLA15.
  • R
    RV
    ARK will add more.
  • M
    Michael
    Hope Cathy Woods has her lipstick ready!
  • T
    Tom
    Cathy woods.isnt it gambling with these kind of stocks.viac,pfe,wmt,cvx they pay a dividend.how about seed for gambling,they only have a 3.7 million share float.and will be feeding china and india
  • k
    kastenz
    Big ABC down since late June. With all these variants, more money will connect the dots. Morgan Stanley has.
  • k
    kastenz
    RV, I see no studies for 'Vaccibody' AND 'Sars-CoV2' infection at Clinicaltrials.gov.
  • M
    Michael
    Plenty of good seats in the front!